Back to Carlyle Group Inc. Carlyle Group Inc.

SYRESYRE
Showing 6 of 9 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in Spyre Therapeutics, Inc

Carlyle Group Inc. previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$282,443

Total Shares Change

-9,620

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$88.78
0
2026-Q1
Unchanged
9,620
0.0%
$485,2330.0%$40.07
0
2025-Q4
New
9,620
-
$315,0550.0%$31.88
36
2025-Q1
Exited
0
-100.0%
$00.0%$17.94
0
2024-Q4
Unchanged
9,620
0.0%
$223,7610.0%$22.54
0
2024-Q3
Unchanged
9,620
0.0%
$282,4430.0%$28.49
0

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used